Search
  • T. Tandstad

The SWENOTECA ABC-study


The SWENOTECA now starts inclusion in the ABC-study. This is a randomized phase III study in stage I seminomatous testicular cancer. Patients with one or two risk factors (stromal invasion of the rete testis and/or tumor size over 4 cm) will be randomized between one course of adjuvant carboplatin (AUC7) or one course of standard BEP.

The ABC-study


85 views

Recent Posts

See All

​​​Contact Us

SWENOTECA

Kreftklinikken, St. Olavs Hospital,

Postboks 3250 Sluppen

7006 Trondheim, Norway

Follow Us

  • w-facebook

swenoteca.org

 © 2015 SWENOTECA